Regulation of ovarian function by growth hormone: potential intervention of ovarian aging

L Han, H Tian, X Guo, L Zhang - Frontiers in Endocrinology, 2023 - frontiersin.org
Growth hormone (GH) is mainly secreted by eosinophils of anterior pituitary gland. GH plays
an important role in regulating the growth and development of many tissues and cells, so it is …

Review of endocrine complications in transfusion-dependent thalassemia

P Faranoush, A Elahinia, A Ziaee, M Faranoush - Iranian Journal of Blood and …, 2023 - ijbc.ir
Beta thalassemia is an inherited genetic disorder that often leads to transfusion
dependence. One of the significant issues that these patients face is increased iron …

Astaxanthin treatment decreases pro‐inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted …

F Fereidouni, L Kashani, F Amidi… - …, 2024 - Springer
Research question In a randomized, triple-blind, placebo-controlled clinical trial (RCT), we
investigated the effect of astaxanthin (AST) on pro-inflammatory cytokines, oxidative stress …

The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response

S Zafardoust, S Kazemnejad, M Fathi-Kazerooni… - Stem Cell Research & …, 2023 - Springer
Background Assisted reproduction faces a significant obstacle in the form of poor ovarian
response (POR) to controlled ovarian stimulation. To address this challenge, mesenchymal …

Comparative efficacy of different growth hormone supplementation protocols in improving clinical outcomes in women with poor ovarian response undergoing …

Z Xu, W Tong, Z Yang, H Zhang, X Chen - Scientific Reports, 2024 - nature.com
Growth hormone (GH) has a long-standing history of use as an adjunctive therapy in the
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …

Effect of growth hormone administration on ameliorating pregnancy outcome in women with advanced maternal age and exploration of its optimized utilization

Q Feng, Y Wang, H Han, H Shen - Frontiers in Endocrinology, 2023 - frontiersin.org
Background Age-related fertility decay is a great challenge for clinicians. Growth hormone
(GH) supplementation has been studied as an adjuvant since late 1980s. However, it has …

Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response: a single-blinded randomized controlled trial

MV Dastjerdi, S Ansaripour, M Ataei… - Contraception and …, 2024 - Springer
Background In the last decade, luteal-phase ovarian stimulation (LPOS) has been
suggested as an alternative controlled ovarian stimulation (COS) protocol for in vitro …

[HTML][HTML] The Impact of Growth Hormone Co-Treatment Duration on Outcomes in IVF/ICSI Cycles Among Poor Ovarian Responders

Z Mohammadshirazi, A Alyasin… - … of Reproduction & …, 2023 - ncbi.nlm.nih.gov
Background: The efficiency of in vitro fertilization is improved by growth hormone (GH)
during ovarian stimulation. Additionally, patients with diabetes experience impaired insulin …

[HTML][HTML] The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic …

F Zakerinasab, Q Behfar, R Parsaee, FA Mojeni… - Turk J Obstet …, 2024 - tjoddergisi.org
To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro
fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian …

[引用][C] Materials and methods Protocol registration

NOSNO Scale - Scientific Reports, 2024